Cannabis
Global Cannabis Partnership Welcomes First Australian Member
The Global Cannabis Partnership (GCP) is pleased to announce its first Australian member: Australian Natural Therapeutics Group (ANTG). ANTG joins multiple leaders in the government-sanctioned cannabis industry who are committed to promoting the safe and responsible production, distribution and consumption of legal cannabis.
ANTG is an independently owned medicinal cannabis company, focused on producing cannabinoid-based medicinal treatments. ANTG’s Australian facilities use research and development (R&D)-led processes to ensure optimal quality of their products, including chemical-free carbon dioxide extraction, high-performance liquid and gas chromatography, cutting-edge distillation tools and complete traceability through the end-to-end production process. ANTG’s research focus has led the company to establish partnerships with a variety of universities in Australia, supporting foundational research for anti-cancer treatments.
ANTG operates two fully licensed locations in Australia with export and product development contracts with Canada, the US and the European Union.
“Being one of the first Australian licensed cannabis companies, we have the opportunity and responsibility to shape the future of the legalized cannabis industry,” says James Gaskell, Partner and Executive Director of ANTG. “The GCP is a perfect partnership opportunity for ANTG as we strive for quality, purity and sustainability at every step of our cultivation, extraction, production processes and with our internal systems and business operations.”
ANTG expands the GCP’s total membership number to 39.
“We’re excited to continue growing our membership across the world,” says Kim Wilson, Executive Director of the GCP. “ANTG’s research background and experience in the Australian cannabis market brings valuable knowledge to the GCP, allowing us to further expand our global mandate.”
The GCP is a partnership of organizations who want to raise the bar with respect to social responsibility in the legal cannabis industry. One of its first activities will be to create the Responsible Cannabis Framework (RCF), which will define the corporate social responsibility (CSR) standards to which all Members agree to adhere. The RCF will be released this summer.
SOURCE Civilized Worldwide Inc. (Civilized)
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
StickIt2 weeks ago
StickIt Technologies Inc. Announces Year-End 2023 Financial Results
-
Cannabis2 weeks ago
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
-
Cannabis2 weeks ago
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
-
Cannabis2 weeks ago
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
-
Cannabis2 weeks ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services
-
Cannabis2 weeks ago
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
transfer7 days ago
IMC to transfer its Oranim Pharmacy shares back to the seller